Skip to content
healthcare.dev

ZITUVIO

NDC 70710-1242, Sitagliptin, tablet, from Zydus Pharmaceuticals (USA) Inc..

Product NDC
70710-1242
Status
Listed
Labeler
Zydus Pharmaceuticals (USA) Inc.
Dosage form
TABLET
Route
ORAL
Product type
HUMAN PRESCRIPTION DRUG
Marketing category
NDA
Application
NDA211566
DEA schedule
None
Request
curl https://api.healthcare.dev/v1/drugs/ndc/70710-1242 \
  -H "Authorization: Bearer $HDEV_API_KEY"

Product

Active ingredients and packages

Active ingredients

  • SITAGLIPTIN100 mg/1

Pharmacologic classes

Dipeptidyl Peptidase 4 Inhibitor [EPC]; Dipeptidyl Peptidase 4 Inhibitors [MoA]

Package NDCNDC-11Package
70710-1242-37071012420330 TABLET in 1 BOTTLE (70710-1242-3)
70710-1242-97071012420990 TABLET in 1 BOTTLE (70710-1242-9)

Linked data

RxNorm, label and prices

RxNorm concepts

Related lookups

  • FDA label sections

    GET /v1/drugs/labels/abfdea45-c0ca-41e3-a510-e89810bc9cfe
  • NADAC price for package 70710124203

    GET /v1/drugs/nadac/70710124203

Use it

Look up 70710-1242 from code or an agent

curl
curl https://api.healthcare.dev/v1/drugs/ndc/70710-1242 \
  -H "Authorization: Bearer $HDEV_API_KEY"
MCP prompt
Using the healthcare.dev MCP server, look up NDC 70710-1242. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.

Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.